These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20220122)

  • 1. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
    Weber YG; Roebling R; Kassubek J; Hoffmann S; Rosenbohm A; Wolf M; Steinbach P; Jurkat-Rott K; Walter H; Reske SN; Lehmann-Horn F; Mottaghy FM; Lerche H
    Neurology; 2010 Apr; 74(14):1108-17. PubMed ID: 20220122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.
    Schneider-Gold C; Bellenberg B; Prehn C; Krogias C; Schneider R; Klein J; Gold R; Lukas C
    PLoS One; 2015; 10(6):e0130352. PubMed ID: 26114298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2.
    Peric S; Brajkovic L; Belanovic B; Ilic V; Salak-Djokic B; Basta I; Rakocevic Stojanovic V
    J Neurol Sci; 2017 Jul; 378():187-192. PubMed ID: 28566162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.
    Kuczynski B; Reed B; Mungas D; Weiner M; Chui HC; Jagust W
    Arch Neurol; 2008 May; 65(5):650-5. PubMed ID: 18474742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neglected brain in myotonic dystrophy types 1 and 2.
    van Engelen BG; de Leeuw FE
    Neurology; 2010 Apr; 74(14):1090-1. PubMed ID: 20220121
    [No Abstract]   [Full Text] [Related]  

  • 6. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.
    Labayru G; Diez I; Sepulcre J; Fernández E; Zulaica M; Cortés JM; López de Munain A; Sistiaga A
    Neuroimage Clin; 2019; 24():102078. PubMed ID: 31795042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1.
    Baldanzi S; Cecchi P; Fabbri S; Pesaresi I; Simoncini C; Angelini C; Bonuccelli U; Cosottini M; Siciliano G
    Neuroimage Clin; 2016; 12():190-7. PubMed ID: 27437180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI findings and cognitive functions in a small cohort of myotonic dystrophy type 1: Retrospective analyses.
    Bajrami A; Azman F; Yayla V; Cagirici S; Keskinkiliç C; Sozer N
    Neuroradiol J; 2017 Feb; 30(1):23-27. PubMed ID: 27837184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical parametric mapping and cluster counting analysis of [18F] FDG-PET imaging in traumatic brain injury.
    Zhang J; Mitsis EM; Chu K; Newmark RE; Hazlett EA; Buchsbaum MS
    J Neurotrauma; 2010 Jan; 27(1):35-49. PubMed ID: 19715400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Involvement in Myotonic Dystrophy Type 1: A Morphometric and Diffusion Tensor Imaging Study with Neuropsychological Correlation.
    Cabada T; Iridoy M; Jericó I; Lecumberri P; Seijas R; Gargallo A; Gomez M
    Arch Clin Neuropsychol; 2017 Jun; 32(4):401-412. PubMed ID: 28164212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separating functional and structural damage in persistent vegetative state using combined voxel-based analysis of 3-D MRI and FDG-PET.
    Juengling FD; Kassubek J; Huppertz HJ; Krause T; Els T
    J Neurol Sci; 2005 Feb; 228(2):179-84. PubMed ID: 15694200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How genetics affects the brain to produce higher-level dysfunctions in myotonic dystrophy type 1.
    Serra L; Petrucci A; Spanò B; Torso M; Olivito G; Lispi L; Costanzi-Porrini S; Giulietti G; Koch G; Giacanelli M; Caltagirone C; Cercignani M; Bozzali M
    Funct Neurol; 2015; 30(1):21-31. PubMed ID: 26214024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury.
    Kato T; Nakayama N; Yasokawa Y; Okumura A; Shinoda J; Iwama T
    J Neurotrauma; 2007 Jun; 24(6):919-26. PubMed ID: 17600509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.
    Minnerop M; Weber B; Schoene-Bake JC; Roeske S; Mirbach S; Anspach C; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Klockgether T; Kornblum C
    Brain; 2011 Dec; 134(Pt 12):3530-46. PubMed ID: 22131273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined neuropsychological and brain imaging study of obstructive sleep apnea.
    Yaouhi K; Bertran F; Clochon P; Mézenge F; Denise P; Foret J; Eustache F; Desgranges B
    J Sleep Res; 2009 Mar; 18(1):36-48. PubMed ID: 19250174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2.
    Krieger B; Schneider-Gold C; Genç E; Güntürkün O; Prehn C; Bellenberg B; Lukas C
    J Neurol; 2024 Aug; 271(8):5525-5540. PubMed ID: 38896263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1.
    Zanigni S; Evangelisti S; Giannoccaro MP; Oppi F; Poda R; Giorgio A; Testa C; Manners DN; Avoni P; Gramegna LL; De Stefano N; Lodi R; Tonon C; Liguori R
    Neuroimage Clin; 2016; 11():678-685. PubMed ID: 27330968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2.
    Kornblum C; Reul J; Kress W; Grothe C; Amanatidis N; Klockgether T; Schröder R
    J Neurol; 2004 Jun; 251(6):710-4. PubMed ID: 15311347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.